Related Experiment Video
Updated: Sep 8, 2025

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Optimal timing for atrial fibrillation patients to undergo catheter ablation
Mingjie Lin1,2, Huan Liang1,2, Kai Zhang1
1State Key Laboratory for Innovation and Transformation of Luobing Theory; Key Laboratory of Cardiovascular Remodeling and Function Research of Chinese Ministry of Education, Chinese National Health Commission, Chinese Academy of Medical Sciences and Shandong Province; Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.
Insights
Early catheter ablation for atrial fibrillation (AF) is recommended, especially for persistent AF, as delayed treatment increases recurrence risk. However, the timing of ablation does not impact major adverse cardiovascular events.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- The optimal timing for catheter ablation in atrial fibrillation (AF) patients is unclear.
- Investigating the relationship between diagnosis-to-ablation time (DAT) and patient outcomes is crucial.
Purpose of the Study:
- To evaluate the impact of diagnosis-to-ablation time (DAT) on AF recurrence.
- To assess the effect of DAT on major adverse cardiovascular and cerebrovascular events (MACCE) after catheter ablation.
Main Methods:
- Prospective observational study of 2097 patients undergoing AF ablation (2016-2020).
- Patients stratified into three DAT groups: ≤1 year, >1 to ≤3 years, and >3 years.
- Cox regression and logistic regression analyses identified predictors of AF recurrence and MACCE.
Main Results:
- Longer DAT was significantly associated with increased AF recurrence (HR 1.003 per month), particularly in persistent AF.
- Left atrial diameter ≥40mm and female sex were independent predictors of AF recurrence.
- DAT did not significantly impact MACCE; age and vascular disease were independent predictors.
Conclusions:
- Early catheter ablation is advisable for maintaining sinus rhythm, especially in persistent AF patients.
- Diagnosis-to-ablation time does not influence the occurrence of MACCE.
- Findings support a shift towards earlier ablation strategies for AF management.
Background:
The optimal timing of undergoing catheter ablation for patients with atrial fibrillation (AF) remains uncertain. We aimed to investigate the impact of diagnosis-to-ablation time (DAT) on AF recurrence and major adverse cardiovascular and cerebrovascular events (MACCE) following catheter ablation.
Methods:
This study analyzed prospective observational data from a single center, including 2097 participants (59.98 ± 10.57 years, 62.7% male) undergoing AF ablation between January 2016 and December 2020. Patients were stratified by DAT: ≤ 1 year, > 1 to ≤ 3 years, and > 3 years. Cox proportional hazards and logistic regression analyses were used to identify predictors of AF recurrence and MACCE.
Results:
During the 46.89 ± 16.46 months follow-up, AF recurs in 512 patients (24.6%). A longer delay per month is significantly associated with a higher recurrence of AF based on multivariable Cox regression analysis [Hazard Ratio (HR) 1.003 (95% CI: 1.001-1.005), p = 0.015]. This association remains consistent in patients with persistent AF (HR compared to DAT ≤ 1 year: 1.548 [95% CI: 1.139-2.102], p = 0.016), but not in those with paroxysmal AF. Left atrial diameter ≥40 mm and female are identified as independent predictors of AF recurrence. The overall impact of DAT on MACCE occurrence is not significant, with age and vascular disease being independent predictors.
Conclusions:
Early catheter ablation is preferable for maintaining sinus rhythm, particularly in persistent AF. However, DAT dose not influence the incidence of MACCE. These findings endorse the paradigm shift towards early ablation.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation III: AED Use
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiac Catheterization I: Pre-Procedure Overview

